Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.26%
SPX
-0.61%
IXIC
-0.93%
FTSE
-0.43%
N225
-1.16%
AXJO
-0.14%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Stocks
Health Care
lsta
Lisata Therapeutics
NASDAQ: LSTA
-0.00 (-0.10%)
5.025
USD
At close at Mar 13, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials
Join our newsletter to keep up to date with us!

Latest Lisata Therapeutics News

prnewswire.com

Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?

Feature Image for interests on Healthcare, Industrials, Stock, Unknown Sector from prnewswire.com
about 1 month ago
prnewswire.com

Are RAPT, ALGT, LSTA, AVO Obtaining Fair Deals for their Shareholders?

Feature Image for interests on Healthcare, Industrials, Stock, Unknown Sector from prnewswire.com
about 1 month ago
prnewswire.com

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

Feature Image for interests on Acquisitions, Biotechnology, Health Care & Hospitals, Healthcare from prnewswire.com
about 2 months ago
prnewswire.com

Neurocrine Biosciences Presents Head-to-Head INGREZZA (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Consumer Defensive, Health Care & Hospitals from prnewswire.com
about 2 months ago
prnewswire.com

Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team

Feature Image for interests on Health Care & Hospitals, Healthcare, Medical Pharmaceuticals, Personnel Announcements from prnewswire.com
2 months ago
prnewswire.com

IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference

Feature Image for interests on Biotechnology, Clinical Trials & Medical Discoveries, Health Care & Hospitals, Healthcare from prnewswire.com
2 months ago
benzinga.com

12 Health Care Stocks Moving In Friday's After-Market Session

Feature Image for interests on Bzi-Tfm, Financial Services, Healthcare, Movers from benzinga.com
2 months ago
prnewswire.com

Nona Biosciences Enters into Collaboration Agreement with Link Cell Therapies to Advance CAR-T Cell Therapies

Feature Image for interests on Biotechnology, Health Care & Hospitals, Healthcare, Medical Pharmaceuticals from prnewswire.com
2 months ago
prnewswire.com

Innovent's Partner Ollin Biosciences Announces Positive Topline Data with Superior Outcomes from a Randomized Head-to-Head Study of IBI324 Compared to Faricimab (Vabysmo) in Diabetic Macular Edema and Wet Age-Related Macular Degeneration

2 months ago
benzinga.com

6 Analysts Have This To Say About Harmony Biosciences Hldgs

Feature Image for interests on Analyst Ratings, Bzi-Aar, Healthcare, Stock from benzinga.com
2 months ago

Latest Cashu News

publisher logo
Cashu

Halper Sadeh probes Lisata Therapeutics' cash‑plus‑CVR sale over fiduciary and disclosure concerns

28 days ago
publisher logo
Cashu

Halper Sadeh Investigates Lisata Therapeutics–Kuva Deal Over Non‑Tradeable CVR Structure

29 days ago
publisher logo
Cashu

Investor Firm Challenges Lisata Therapeutics–Kuva Deal Over Non‑Tradeable CVRs

about 1 month ago